We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
127 hedge funds and large institutions have $812M invested in Intra-Cellular Therapies Inc. in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 32 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
91% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 32
4% less funds holding
Funds holding: 132 → 127 (-5)
17% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 23
47% less capital invested
Capital invested by funds: $1.53B → $812M (-$721M)
52% less call options, than puts
Call options by funds: $5M | Put options by funds: $10.4M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
127
Holders Change
-5
Holders Change %
-3.79%
% of All Funds
3.38%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
19
Increased
61
Reduced
32
Closed
23
Calls
$5M
Puts
$10.4M
Net Calls
-$5.44M
Net Calls Change
+$5.27M
Top Buyers
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$11.7M |
| 2 |
O
OrbiMed
New York
|
+$9.8M |
| 3 |
Millennium Management
New York
|
+$9.51M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$6.86M |
| 5 |
Renaissance Technologies
New York
|
+$6.31M |
Top Sellers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$18.9M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$6.63M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$5.59M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$4.13M |
| 5 |
VAM
Visium Asset Management
New York
|
-$4.11M |
